Senolytics: Clearing Senescent ‘Zombie’ Cells for Systemic Tissue Renewal

As cells accumulate DNA damage, telomere shortening, or metabolic stress, they enter a state called . Instead of undergoing programmed cell death (apoptosis), these non-dividing “zombie cells” remain active and secretes toxic compounds into surrounding tissues.

### The Senescence-Associated Secretory Phenotype ()
release a destructive cocktail known as the SASP, containing pro-inflammatory cytokines, matrix metalloproteinases (MMPs), and reactive oxygen species. Over time, SASP degrades healthy extracellular matrix proteins, triggers chronic tissue inflammation (““), and forces neighboring healthy cells into senescence.

### The Action of Senolytic Compounds
are small molecules designed to transiently disable the survival pathways (SCAPs) that keep senescent cells alive:
* **:** A naturally occurring flavonoid shown in preclinical studies to possess potent, targeted senolytic activity across multiple tissue types.
* **:** Works synergistically with compounds like Dasatinib to disrupt anti-apoptotic networks in senescent endothelial and mesenchymal cells.

### Impact on
Intermittent clearance of senescent cells decreases systemic SASP burden, allowing endogenous stem cells to proliferate, deposit fresh structural collagen, and restore youthful organ function.